All News #Library
Biotech
Neuron23 Raises $96.5M, Doses First Parkinson’s Patient
24 Jun 2025 //
BUSINESSWIRE
Neuron23`s PNAS Publication Highlights TYK2 in Neuroimmunology
25 Mar 2025 //
BUSINESSWIRE
Neuron23 Doses NEU-111 in Phase 1 Immune Disorder Trial
03 Dec 2024 //
BUSINESSWIRE
Neuron23 to Use Roche’s Digital Biomarker in Parkinson’s Trial
19 Nov 2024 //
BUSINESSWIRE
Neuron23 Unveils Phase 2 Trial in Early Parkinson’s Disease
19 Nov 2024 //
BUSINESSWIRE

Market Place
Sourcing Support